Rani Therapeutics Holdings, Inc. (RANI) NASDAQ
1.32
+0.03(+2.33%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.32
+0.03(+2.33%)
Currency In USD
| Market Cap | 39.01M |
| Enterprise Value | 64.96M |
| P/E Ratio | -1.7 |
| PEG Ratio | -0.13 |
| Price/Sales Ratio | 80.29 |
| Price/Book Ratio | -6.14 |
| Enterprise/Revenue | 91.47 |
| Enterprise/EBITDA | -2.56 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | -23.6 |
| Operating Margin | -37.28 |
| Return On Assets | -2.79 |
| Return On Equity | 7.81 |
| Revenue | 1.03M |
| Revenue/Share | 0.03 |
| Gross Profit | 1.03M |
| EBITDA | -50.52M |
| Net Income | -30.02M |
| Diluted EPS | -1.05 |
| Total Cash | 4.14M |
| Total Cash/Share | 0.11 |
| Total Debt | 17.55M |
| Total Debt/Equity | -2.23 |
| Current Ratio | 0.26 |
| Book Value Per Share | -0.33 |
| 52-Week Change | -12.58 |
| 52-Week High | 3.87 |
| 52-Week Low | 0.39 |
| Moving Average 50 Days | 1.33 |
| Moving Average 200 Days | 1.03 |
| Average Volume | 1.29M |
| Shares Outstanding | 72.99M |
| % Held by Institutions | 122.6 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |